Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy

Abstract Objective Endoscopic ultrasound (US)‐guided radiofrequency ablation (RFA) has been investigated for pancreatic ductal adenocarcinoma (PDAC) but studies are limited and heterogeneous. Computed tomography (CT) scan features may predict RFA response after chemotherapy but their role is unexplo...

Full description

Saved in:
Bibliographic Details
Main Authors: Gemma Rossi, Maria Chiara Petrone, Marco Schiavo Lena, Luca Albarello, Diego Palumbo, Sabrina Gloria Giulia Testoni, Livia Archibugi, Matteo Tacelli, Piera Zaccari, Giuseppe Vanella, Laura Apadula, Stefano Crippa, Giulio Belfiori, Michele Reni, Massimo Falconi, Claudio Doglioni, Francesco De Cobelli, Andrew J Healey, Gabriele Capurso, Paolo Giorgio Arcidiacono
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:DEN Open
Subjects:
endoscopic ultrasound
ex‐vivo
neoadjuvant chemotherapy
pancreatic adenocarcinoma
radiofrequency ablation
Online Access:https://doi.org/10.1002/deo2.152
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/deo2.152

Similar Items